Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

27

Revenue 2017

Gilenya

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gilenya was produced by Novartis.

Novartis: pipeline will generate 60 filings in three years

Novartis: pipeline will generate 60 filings in three years Mayzent is a follow-up to Novartis’ blockbuster MS therapy Gilenya (fingolimod), which brought in $2.5bn in the first nine months of the year and is facing the threat of

Novartis files for approval of MS drug in EU, US

Novartis files for approval of MS drug in EU, US Siponimod (BAF312) – which is a follow-up to Novartis’ established MS therapy Gilenya (fingolimod) – is the first and so far only drug to have demonstrated it can delay the progression of ... That’s the same mechanism as $3bn-a-year product

Dismay as NICE rejects Roche’s MS drug Ocrevus

Dismay as NICE rejects Roche’s MS drug Ocrevus such as Novartis’ Gilenya (fingolimod) and Biogen’s Tecfidera (dimethyl fumarate).

Novartis buys gene therapy firm AveXis for $8.7bn

Novartis buys gene therapy firm AveXis for $8.7bn some big sellers like cancer drug Afinitor and Gilenya for multiple sclerosis in 2019, according to a report on aktiencheck.de.

FDA turns down Celgene’s filing for multiple sclerosis drug

FDA turns down Celgene’s filing for multiple sclerosis drug So far there is just one S1P modulator - Novartis’ Gilenya (fingolimod) - on the market. ... Gilenya has some off-target effects, such as slowing of the heart that requires monitoring on first dosing, and has been linked to liver function abnormalities.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

The big issue
Whether you want to lead or follow, you need to understand the elephant in the C-suite...
INFOGRAPHIC 02: The Importance of clinical study websites
Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
Working with, Advocating for, and Empowering Patients
A holistic view of how to work with patients virtually...

Infographics